Original news and analysis on international IP policy
A new report released today by the World Health Organization found that 17 neglected tropical diseases can be controlled. If strategies set out in the report are implemented widely, “they can substantially reduce the disease burden, breaking a cycle of infection, disability and lost opportunities that keep people in poverty, WHO Director General Margaret Chan said in a press release.
Now available for Intellectual Property Watch readers: Email alerts for the IP-Watch Burble microblog, our breaking news briefs. A free service available to all, just sign up for email alerts here if you don't already receive them.
If you already receive IP-Watch email alerts, just scroll to the bottom of any email you receive (like this one) and click the link under "If you would like to modify the settings of your subscription," which takes you to your individualised settings. Then add Burble to your categories.
And of course you can also follow us on Twitter or by RSS feed, see www.ip-watch.org.
If you have any questions, please contact us at info@ip-watch.ch.
International public health in Geneva is no longer just the province of the World Health Organization. Dozens of intergovernmental and non-governmental agencies, along with financing organisations and partnerships, have headquartered their operations in Geneva, making the mid-sized Swiss city a public health capital of the world. Many of these organisations are engaged in addressing the critical interface between public health, development and innovation, including intellectual property rights. The following is a backgrounder and guide to many of the organisations working on these issues in town.
The pandemic threat of the H1N1 or "swine flu" virus has now passed, World Health Organization Director General Margaret Chan announced today.
Are counterfeit products first and foremost a threat to human health and safety or is provoking anxiety just a clever way for wealthy nations to create sympathy for increased protection of their intellectual property rights? In Geneva the debate is raging, but a look at a sample of coverage of this issue in the world’s news media shows it can vary greatly.
A group of policymakers and other experts met this month in Geneva to discuss counterfeit and unsafe products and wrestled with possible balanced solutions to the problem. The event was hosted by the United States mission and supported by the US Chamber of Commerce. It included US Ambassador to the UN Betty E. King, among dozens of others.
Key international agencies for health, trade and intellectual property on Friday jointly organised a symposium on access to medicines in an effort to gather information and expertise as a basis of a collaborative response to the challenges of public health.
“Exactly a year ago, a very bad decision was taken” by the World Health Organization that now seems “unscientific and irrational,” said Council of Europe parliamentarian Paul Flynn in a late June presentation of a new report on the WHO's actions during the 2009 influenza pandemic.
But opinions heard at an ongoing review of the WHO’s pandemic response were mixed, with some praising the organisation’s work to protect public health and others critiquing what they say is suspicious secrecy.
The final step in the establishment of a patent pool under international drug-purchasing mechanism UNITAID was taken today, the UN body announced.
"At no time, not for one second, did commercial interests enter my decision-making," Director General Margaret Chan of the World Health Organization declaration in a letter today defending the organisation's increasingly scrutinised response to an outbreak of H1N1, or 'swine flu.'
Global health authorities have been guilty of "grave shortcomings" in transparency and accountability to the public good in their handling of the pandemic influenza outbreak says a new draft resolution from the intergovernmental Council of Europe. A related investigative report from the British Medical Journal found evidence of "declarable financial conflicts of interests" among the experts advising the World Health Organization. But WHO denies any wrongdoing.
World Health Organization members today took an important step closer to finding new ways to finance research and development into diseases afflicting developing countries.